What has happened to Ozempic (semaglutide) company “stock price” over time?
“Ozempic” is the brand name for semaglutide. The stock price history you’re likely looking for depends on which company’s shares you mean:
- If you mean the manufacturer of Ozempic, that is typically Novo Nordisk A/S (ticker: NVO on NYSE ADRs; NOVO-B on Nasdaq Copenhagen for B shares).
- If you mean a U.S. distributor/partner or another related company, you’ll need to specify which ticker.
Which ticker should you use for Ozempic stock history (NVO vs something else)?
Ozempic itself is not publicly traded; the stock history is for the company that owns/markets it. For “Ozempic stock price history,” most searches refer to Novo Nordisk (NVO / NOVO-B). If you tell me the ticker you want, I can format the history for that exact listing.
What stock-price milestones typically line up with Ozempic demand news?
News and investor expectations around Ozempic and similar GLP-1 drugs often move Novo Nordisk’s shares, including:
- Earnings releases (guidance on production capacity, demand, and sales)
- Regulatory updates for semaglutide products
- Supply constraints and manufacturing expansion
- Competition from other GLP-1 and obesity/diabetes drugs
If you share the period you want (for example, “last 5 years” or “since 2020”), I can map out the key eras and what drove big moves.
Can you share a specific “stock price history” format you want?
Common ways people ask for this include:
- Daily or weekly price history for a date range
- Year-by-year performance (annual return)
- Major highs/lows and drawdowns
- A chart-style narrative tied to earnings/regulatory events
Reply with:
1) Which ticker/listing (e.g., NVO ADR or NOVO-B), and
2) The date range you want (e.g., 2017–2026, 2020–2024, or “since Ozempic launch”).
Sources
- None provided (the information needed to list historical prices/dates isn’t included in the prompt).